DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Petraitis V, Petraitiene R, Katragkou A. et al.
Combination therapy with Ibrexafungerp (formerly SCY-078), a first-in-class triterpenoid inhibitor (1 → 3)-β-D-glucan synthesis, and Isavuconazole for treatment of experimental invasive pulmonary aspergillosis.
Antimicrob Agents Chemother 2020;
64: e02429-19
DOI: 10.1128/AAC.02429-19.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.